ANN ARBOR, Mich., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Adeona Pharmaceuticals, Inc. (AMEX:AEN - News), a late-stage specialty pharmaceutical company developing innovative candidates for the treatment of autoimmune and central nervous system diseases, announced that it will present at the Rodman & Renshaw 10th Annual Healthcare Conference at the Palace Hotel in New York on Tuesday, November 11th at 4:05 pm EST. Mr. Nicholas Stergis, chief executive officer of Adeona, will discuss the Company's business strategy and provide an update on its product pipeline.

Mr. Stergis will provide an overview of Adeona's market positioning, financial performance, and strategic direction. Access to the webcast is available by logging on to the conference website http://www.wsw.com/webcast/rrshq14/aen/ or by going to Adeona's website at http://www.adeonapharma.com.

About Adeona Pharmaceuticals, Inc.

Adeona Pharmaceuticals, Inc. is a late-stage pharmaceutical company that is developing proprietary drug candidates for the treatment of autoimmune and central nervous system diseases. Adeona's strategy is to exclusively in-license proprietary, clinical-stage drug candidates and to complete the further clinical testing, manufacturing, regulatory requirements and seek marketing authorizations. Adeona is focused on treating rheumatoid arthritis (RA), dry age-related macular degeneration (AMD), multiple sclerosis (MS), and fibromyalgia. For further information, please visit http://www.adeonapharma.com.

          Adeona Pharmaceuticals, Inc. 
          Nicholas Stergis, Chief Executive Officer
          (734) 332-7800

          Redington, Inc.
          Investor Relations
          Thomas Redington 
          203-222-7399
          www.redingtoninc.com